Peptidni agonisti receptorja za glukagonu podobni peptid-1 ter njihova uporaba pri zdravljenju sladkorne bolezni tipa 2 in debelosti
Deželak, Matjaž (Author), Bavec, Aljoša (Author)

URLURL - Presentation file, Visit http://www.sfd.si/?mod=catalog&action=view&group=1 This link opens in a new window

In the beginnings of pharmaceutical, pharmacological, and pharmacotherapeutical sciences small molecules played the main role as chemical synthesis, purification, and drug delivery and targeting were relatively simple. Moreever, high degree of chemical stability and biological availability both worked in their favour. Later on, technologies for achieving the appropriate degree of above mentioned limiting factors improved, and larger, polymeric molecules became useful. Among them, the most important are peptides and proteins, which have crucial natural role in organisms physiology. This review article discusses peptide drugs in general and it continues with glucagon like peptide-1 (GLP-1) being used for treatment of diabetes mellitus type 2 and obesity. Because of the fact that the peptide drug-based therapy of these two illnesses is relatively new it still has quite some imperfections. That is why directions to achieve a better treatment efficacy which are based on our latest research are presented at the end.

Keywords:peptidne učinkovine, sladkorna bolezen tipa 2, debelost
Work type:Not categorized (r6)
Tipology:1.02 - Review Article
Organization:MF - Faculty of Medicine
Publisher:Slovensko farmacevtsko društvo
Number of pages:str. 211-217
Numbering:Letn. 64, št. 3
ISSN on article:0014-8229
COBISS.SI-ID:30773721 Link is opened in a new window
Average score:(0 votes)
Your score:Voting is allowed only to logged in users.
AddThis uses cookies that require your consent. Edit consent...

Record is a part of a journal

Title:Farmacevtski vestnik
Shortened title:Farm. vestn.
Publisher:Slovensko farmacevtsko društvo
COBISS.SI-ID:3105794 This link opens in a new window

Secondary language

Title:Glucagon like peptide-1 receptor agonists and their application in treatment of diabetes mellitus type 2 and obesity
Keywords:peptide drugs, type 2 diabetes mellitus, obesity

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:


Leave comment

You have to log in to leave a comment.

Comments (0)
0 - 0 / 0
There are no comments!